Sequana Medical NV
SQNMF
$1.22
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -100.00% | -100.00% | -72.84% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -100.00% | -100.00% | -72.84% |
| Cost of Revenue | -- | -- | -99.51% | -99.51% | -70.95% |
| Gross Profit | -- | -- | -100.15% | -100.15% | -73.46% |
| SG&A Expenses | -2.34% | -10.22% | -32.74% | -31.38% | -36.82% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -32.77% | -31.52% | -- |
| Total Operating Expenses | -3.95% | -11.70% | -37.36% | -36.10% | -38.40% |
| Operating Income | 2.91% | 10.74% | 35.90% | 34.61% | 37.55% |
| Income Before Tax | -75.05% | -60.93% | -108.38% | -112.57% | 33.29% |
| Income Tax Expenses | -8.67% | -15.95% | -36.63% | -35.28% | -43.56% |
| Earnings from Continuing Operations | -73.95% | -59.92% | -106.48% | -110.64% | 33.45% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -73.95% | -59.92% | -106.48% | -110.64% | 33.45% |
| EBIT | 2.91% | 10.74% | 35.90% | 34.61% | 37.55% |
| EBITDA | 7.80% | 15.23% | 36.07% | 34.78% | 37.87% |
| EPS Basic | -7.38% | 1.29% | -41.71% | -44.54% | 47.95% |
| Normalized Basic EPS | -8.00% | 0.70% | -43.00% | -45.87% | 47.82% |
| EPS Diluted | -7.38% | 1.29% | -41.71% | -44.54% | 47.95% |
| Normalized Diluted EPS | -8.00% | 0.70% | -43.00% | -45.87% | 47.82% |
| Average Basic Shares Outstanding | 62.03% | 62.03% | 45.70% | 45.70% | 27.83% |
| Average Diluted Shares Outstanding | 62.03% | 62.03% | 45.70% | 45.70% | 27.83% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |